ARCHIVES

NCI CTEP-Approved Trials For the Month of September

This article is from The Cancer Letter archive.

Vol. 37 No. 9 | September 26, 2014

Download PDF Visit The Full Archive

Related Articles

“Cancer Is a Disappearing Disease” and Other Controversies

January 3, 1986

Phase III Trial In Recurrent Disease Shows Lower Risk of Progression or Death by 34%

June 28, 2013

ACS President Lawrence Emphasizes Prevention Gains Since 1971

April 10, 1992

Barret’s Less of a Risk Factor For Cancer of the Esophagus

June 24, 2011

FDA IND Approval Of New Cancer Drug Is First Based On Phase 1 Clinical Trials In Europe

December 5, 1986

BRAF Mutation Testing Classifies Indeterminate FNA Samples

March 29, 2013